摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氟-4-氰基吡啶 | 113770-88-0

中文名称
3-氟-4-氰基吡啶
中文别名
——
英文名称
3-fluoroisonicotinonitrile
英文别名
3-fluoro-4-cyanopyridine;3-fluoropyridine-4-carbonitrile;4-cyano-3-fluoropyridine
3-氟-4-氰基吡啶化学式
CAS
113770-88-0
化学式
C6H3FN2
mdl
MFCD04112524
分子量
122.102
InChiKey
RFQHDTRSEWCXJP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    178.8℃
  • 密度:
    1.24
  • 闪点:
    61.9℃

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    36.7
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险等级:
    6.1
  • 海关编码:
    2933399090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H317,H319

SDS

SDS:11410b40bbbdb309a5df57d9c51b721b
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Fluoro-4-cyanopyridine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-Fluoro-4-cyanopyridine
CAS number: 113770-88-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H3FN2
Molecular weight: 122.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN3439 Class: 6.1 Packing group: III
Proper shipping name: NITRILES, TOXIC, SOLID, N.O.S. (3-Fluoro-4-cyanopyridine)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    3-氟-4-氰基吡啶一水合肼 作用下, 以 乙醇 为溶剂, 反应 16.0h, 以100%的产率得到1H-吡唑并[3,4-c]吡啶-3-胺
    参考文献:
    名称:
    (Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use
    摘要:
    本申请涉及新型取代的(氮杂)吡啶吡唑吡嘧啶酮和吲唑吡嘧啶酮,以及它们的制备方法,这些化合物可单独或组合使用于治疗和/或预防疾病的方法中,特别是用于治疗和/或预防患有或不患有基础遗传或获得性出血性疾病的患者的急性和复发性出血,其中出血与来自月经过多、产后出血、出血性休克、创伤、手术、移植、中风、肝病、遗传性血管性水肿、鼻血和血液性关节积血后的滑膜炎和软骨损伤等疾病或医疗干预有关。
    公开号:
    US20150126449A1
点击查看最新优质反应信息

文献信息

  • Synthesis of Sterically Hindered Primary Amines by Concurrent Tandem Photoredox Catalysis
    作者:Michael C. Nicastri、Dan Lehnherr、Yu-hong Lam、Daniel A. DiRocco、Tomislav Rovis
    DOI:10.1021/jacs.9b10871
    日期:2020.1.15
    methodologies exist for amine synthesis, but the direct synthesis of primary amines with a fully substituted α carbon center is an underdeveloped area. We report a method which utilizes photoredox catalysis to couple readily available O-benzoyl oximes with cyanoarenes to synthesize primary amines with fully substituted α-carbons. We also demonstrate that this method enables the synthesis of amines with α-trifluoromethyl
    伯胺是活性药物成分 (API) 及其中间体的重要结构基序,也是用于生物或催化应用的配体库的成员。胺合成有许多化学方法,但直接合成具有完全取代的 α 碳中心的伯胺是一个欠发达的领域。我们报告了一种利用光氧化还原催化将容易获得的 O-苯甲酰基肟与氰基芳烃偶联以合成具有完全取代的 α-碳的伯胺的方法。我们还证明该方法能够合成具有 α-三氟甲基官能团的胺。根据实验和计算结果,
  • Structure–Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and <i>in Vivo</i> Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers
    作者:Romain Siegrist、Davide Pozzi、Gaël Jacob、Caterina Torrisi、Kilian Colas、Bertrand Braibant、Jacques Mawet、Thomas Pfeifer、Ruben de Kanter、Catherine Roch、Melanie Kessler、Olivier Corminboeuf、Olivier Bezençon
    DOI:10.1021/acs.jmedchem.6b01356
    日期:2016.12.8
    availability of numerous antiepileptic drugs, 20–30% of epileptic patients are pharmacoresistant with seizures not appropriately controlled. Consequently, new strategies to address this unmet medical need are required. T-type calcium channels play a key role in neuronal excitability and burst firing, and selective triple T-type calcium channel blockers could offer a new way to treat various CNS disorders
    尽管可以使用多种抗癫痫药,但仍有20%至30%的癫痫患者对药物具有耐药性,癫痫发作没有得到适当控制。因此,需要新的策略来解决这种未满足的医疗需求。T型钙通道在神经元兴奋性和爆发放电中起关键作用,选择性的三重T型钙通道阻滞剂可能为治疗各种中枢神经系统疾病,特别是癫痫病提供新途径。在这里,我们描述了新的1,4-苯二氮卓类药物作为脑渗透剂和选择性三重T型钙通道阻滞剂的鉴定。从外消旋化合物4开始,优化工作导致制备了吡啶二氮杂卓31c具有改善的理化性质,溶解度和代谢稳定性。外消旋混合物通过手性制备型HPLC分离,所得铅化合物(3 R,5 S)-31c在广义非惊厥性癫痫样癫痫的WAG / Rij-rat模型中显示出有希望的功效。
  • (Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use
    申请人:BAYER PHARMA AKTIENGESELLSCHAFT
    公开号:US20150126449A1
    公开(公告)日:2015-05-07
    The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.
    本申请涉及新型取代的(氮杂)吡啶吡唑吡嘧啶酮和吲唑吡嘧啶酮,以及它们的制备方法,这些化合物可单独或组合使用于治疗和/或预防疾病的方法中,特别是用于治疗和/或预防患有或不患有基础遗传或获得性出血性疾病的患者的急性和复发性出血,其中出血与来自月经过多、产后出血、出血性休克、创伤、手术、移植、中风、肝病、遗传性血管性水肿、鼻血和血液性关节积血后的滑膜炎和软骨损伤等疾病或医疗干预有关。
  • [EN] DEMETHYLASE ENZYMES INHIBITORS<br/>[FR] INHIBITEURS D'ENZYMES DE DÉMÉTHYLASE
    申请人:GLAXO GROUP LTD
    公开号:WO2013143597A1
    公开(公告)日:2013-10-03
    A compound of formula (I) and its use as an inhibitor of one or more histone demethylase enzymes.
    一种具有化学式(I)的化合物及其作为一个或多个组蛋白去甲基化酶的抑制剂的用途。
  • Reductive Arylation of Aliphatic and Aromatic Aldehydes with Cyanoarenes by Electrolysis for the Synthesis of Alcohols
    作者:Xiao Zhang、Chao Yang、Han Gao、Lei Wang、Lin Guo、Wujiong Xia
    DOI:10.1021/acs.orglett.1c00920
    日期:2021.5.7
    An electroreductive arylation reaction of aliphatic and aromatic aldehydes as well as ketones with electro-deficient (hetero)arenes is described. A variety of cyano(hetero)arenes and carbonyl compounds, especially aliphatic aldehydes, have been examined, providing secondary and tertiary alcohols in moderate to good yields. Mechanistic studies, including cyclic voltammetry (CV), electron paramagnetic
    描述了脂族和芳族醛以及酮与电缺陷(杂)芳烃的电还原芳基化反应。已经研究了各种氰基(杂)芳烃和羰基化合物,尤其是脂肪族醛,以中等到良好的收率提供了仲醇和叔醇。包括循环伏安法(CV),电子顺磁共振(EPR)和分裂细胞实验在内的机理研究均支持通过阴极还原再进行自由基-自由基交叉偶联来生成脂肪族酮基和持久性杂芳基阴离子。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-